1) antithyroid drug
![点击朗读](/dictall/images/read.gif)
抗甲状腺药
1.
Effect of low dose thyroxine with antithyroid drug on recurrence rate of Graves disease;
![点击朗读](/dictall/images/read.gif)
小剂量甲状腺素联合抗甲状腺药物治疗对Graves病复发率的影响
2) antithyroid drugs
![点击朗读](/dictall/images/read.gif)
抗甲状腺药
1.
Comparative study on ~(131)I and antithyroid drugs to the treatment of hyperthyroidism combined with diabetes mellitus
~(131)I和抗甲状腺药物治疗糖尿病合并甲状腺机能亢进症临床观察
2.
Objective To study the effect of iodized salt on treatment with antithyroid drugs in Graves disease.
目的 探讨碘盐对抗甲状腺药物 (ATD)治疗 Graves病 (GD)疗效的影响 ,从而为临床上碘盐的合理应用提供依据。
4) Antithyroid drugs
![点击朗读](/dictall/images/read.gif)
抗甲状腺药物
1.
Clinical analysis of 8 cases of agranulocytosis induced by antithyroid drugs
![点击朗读](/dictall/images/read.gif)
抗甲状腺药物致粒细胞缺乏症8例临床分析
2.
Objective:To investigate the clinical features,the diagnosis and treatment of agranulocytosis induced by antithyroid drugs.
目的:探讨抗甲状腺药物(ATD)引起粒细胞缺乏症的病因、临床特点、诊治方法。
3.
Antithyroid drugs may influ-ence the efficacy of 131I,the possible mechanism might be that antithyroid drugs change the effective half-time and(or) uptake of 131I.
抗甲状腺药物影响131I疗效的机理可能在于改变了131I的有效半衰期和(或)甲状腺对131I的摄取率。
5) antithyroid drug
![点击朗读](/dictall/images/read.gif)
抗甲状腺药物
1.
Objective To explore the effect of granulocyte colony-stimulating factor(G-CSF) on agranulocytosis induced by antithyroid drugs.
目的探讨粒细胞集落刺激因子对抗甲状腺药物(ATD)所致不同程度粒细胞缺乏症疗效的差异。
2.
Antithyroid drug is one of the main therapeutic method in treatment Graves′ s disease,of which the common adverse effects are granulopenia and agraneulocytosis.
抗甲状腺药物(ATD)是治疗Graves病的主要方法之一,但治疗中出现的最常见的不良反应为粒细胞减少和粒细胞缺乏。
3.
Objective To evaluate the relationship between the incidence of abnormal thyroid function of newborns and maternal hyperthyroidism with antithyroid drug therapy.
目的探讨妊娠期间母亲合并甲状腺功能亢进症(甲亢)和服用抗甲状腺药物(ATDs)对新生儿甲状腺功能的影响。
6) ATD
![点击朗读](/dictall/images/read.gif)
抗甲状腺药物
1.
Objective:To observe the relationship of the TSH and prognosis of GD with ATD,and to find out the index related the prognosis.
目的:分析Graves病(GD)甲亢在抗甲状腺药物(ATD)治疗后血清促甲状腺激素(TSH)值转归情况及其与治疗预后的关系,为寻找预后指标提供依据。
2.
Objective To investigate the influence of ATD on 131 I treatment in Graves disease and to evaluate reasonable dosage of 131 I for the treatment of Graves disease.
目的 探讨ATD(抗甲状腺药物 )对Graves’病13 1I治疗疗效的影响程度 ,指导临床更加合理地使用13 1I治疗剂量 。
3.
Objective: there is a transitory increase in levels of thyrotrophic receptors antibodies (TRAb) after radioiodine therapy (~(131)I) in hyperthyroid Graves disease, Immunosuppressive effects of anti thyroid drugs (ATD) are still a matter of debate.
目的 Graves病患者~(131)I治疗后血清促甲状腺激素受体抗体(TRAb)有短暂升高,抗甲状腺药物(ATD)的是否具有免疫调节作用目前仍存在争论,本研究通过观察ATD干预治疗对~(131)I治疗后血清TRAb的影响,探讨ATD的免疫调节作用及TRAb与预后的关系。
补充资料:抗甲状腺药
分子式:
CAS号:
性质:一类主要抑制甲状腺激素合成、释放或破坏甲状腺功能,达到暂时或长期控制甲亢症状的药物。常用药物包括硫脲类(如丙基硫氧嘧啶、他巴唑等)、碘和碘化物、放射性碘和肾上腺素β-受体阻断剂等。硫脲类药物抑制甲状腺激素合成,缓解和消除甲亢症状。碘和碘化物大剂量时主要抑制甲状腺激素释放及抗促甲状腺激素作用等,可用于甲亢危象和甲亢术前准备。放射性碘给药后分布在甲状腺,其产生的β射线辐射损伤甲状腺,类似手术切除部分甲状腺。β-受体阻断剂有助于控制甲亢病人交感-肾上腺系统兴奋所致症状,适当减少甲状腺素分泌。
CAS号:
性质:一类主要抑制甲状腺激素合成、释放或破坏甲状腺功能,达到暂时或长期控制甲亢症状的药物。常用药物包括硫脲类(如丙基硫氧嘧啶、他巴唑等)、碘和碘化物、放射性碘和肾上腺素β-受体阻断剂等。硫脲类药物抑制甲状腺激素合成,缓解和消除甲亢症状。碘和碘化物大剂量时主要抑制甲状腺激素释放及抗促甲状腺激素作用等,可用于甲亢危象和甲亢术前准备。放射性碘给药后分布在甲状腺,其产生的β射线辐射损伤甲状腺,类似手术切除部分甲状腺。β-受体阻断剂有助于控制甲亢病人交感-肾上腺系统兴奋所致症状,适当减少甲状腺素分泌。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条